News & Updates
Personalized Immunotherapy Shows Promise Beyond Cancer
Tuesday, September 27, 2022
Last month, Philly Fights Cancer: Round 4 honoree, Time Magazine “Most Influential Person of the Year”, and Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at Penn Medicine Dr. Carl June was featured on podcast “Science Friday” to discuss the many ways in which personalized immunotherapy is revolutionizing what’s possible in cancer care.
CAR T cell therapy, a type of immunotherapy in which a patient’s own immune cells are modified to create a hybrid immune cell that destroys cancer cells, was first developed over a decade ago. Now, researchers are continuing to find success in treating new types of blood cancers with the therapy, and are working on applying the technology to solid state cancers like those of the pancreas and brain. Scientists are also at the early stages of testing CAR T cells to treat autoimmune diseases like multiple sclerosis (MS) and lupus.
Philly Fights Cancer has been raising funding for translational research and clinical trials for CART T therapy since its inception in 2015. Clinical trials have been instrumental in the development and FDA approval of CAR T.
Science Friday host Ira Flatow talks with Dr. Carl June, one of the pioneers of CAR T cell therapy, a professor of immunotherapy and director of the Center for Cellular Immunotherapies at the University of Pennsylvania, based in Philadelphia.
The full episode can be heard here:
https://www.sciencefriday.com/segments/car-t-cell-therapy/
Share this post
Last month, Philly Fights Cancer: Round 4 honoree, Time Magazine “Most Influential Person of the Year”, and Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at Penn Medicine Dr. Carl June was featured on podcast “Science Friday” to discuss the many ways in which personalized immunotherapy is revolutionizing what’s possible in cancer care.
CAR T cell therapy, a type of immunotherapy in which a patient’s own immune cells are modified to create a hybrid immune cell that destroys cancer cells, was first developed over a decade ago. Now, researchers are continuing to find success in treating new types of blood cancers with the therapy, and are working on applying the technology to solid state cancers like those of the pancreas and brain. Scientists are also at the early stages of testing CAR T cells to treat autoimmune diseases like multiple sclerosis (MS) and lupus.
Philly Fights Cancer has been raising funding for translational research and clinical trials for CART T therapy since its inception in 2015. Clinical trials have been instrumental in the development and FDA approval of CAR T.
Science Friday host Ira Flatow talks with Dr. Carl June, one of the pioneers of CAR T cell therapy, a professor of immunotherapy and director of the Center for Cellular Immunotherapies at the University of Pennsylvania, based in Philadelphia.
The full episode can be heard here:
https://www.sciencefriday.com/segments/car-t-cell-therapy/